These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6861805)

  • 1. First results of immunotherapy with immunoglobulin G in multiple sclerosis patients.
    Schuller E; Govaerts A
    Eur Neurol; 1983; 22(3):205-12. PubMed ID: 6861805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive immunosuppression in patients with disseminated sclerosis. II. Tolerance to equine IgG and effect on immunoglobulin and complement levels.
    Jones VE; Lance EM; Abbosh J; Graves HE
    Clin Exp Immunol; 1975 Jul; 21(1):13-22. PubMed ID: 810281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune profile of women experiencing recurrent spontaneous abortions of unknown aetiology.
    Kilpatrick DC; Liston WA; Neill G; Maxwell C
    Dis Markers; 1989; 7(2):87-94. PubMed ID: 2731410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis with reduced and with normal levels of complement in the blood. Clinical and genetic correlation.
    Trouillas P; Moindrot J; Betuel H; Quincy C; Aimard G; Devic M
    Rev Neurol (Paris); 1976 Oct; 132(10):684-704. PubMed ID: 1006010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA antigens in multiple sclerosis in Alsace.
    Rumbach L; Tongio MM; Warter JM; Marescaux C; Grange D; Mayer S; Collard M
    Biomed Pharmacother; 1985; 39(7):385-9. PubMed ID: 3830266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.
    Storch MK; Piddlesden S; Haltia M; Iivanainen M; Morgan P; Lassmann H
    Ann Neurol; 1998 Apr; 43(4):465-71. PubMed ID: 9546327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in serum immunoglobulin concentrations in patients with multiple sclerosis during the treatment with ACTH.
    Maciejek Z; Rebeś Z; Kubasiewicz B
    Arch Immunol Ther Exp (Warsz); 1981; 29(2):141-4. PubMed ID: 6272663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current problems in multiple sclerosis (immunogenetic aspect) (review of the literature)].
    Khondkarian OA; Zavalishin IA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(2):292-300. PubMed ID: 76384
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum immunoglobulin and complement profile in parasitic diseases.
    Saha K; Sarkar N; Paul DN; Ray D
    Indian J Med Res; 1979 Jul; 70():22-32. PubMed ID: 500156
    [No Abstract]   [Full Text] [Related]  

  • 10. HLA, lymphocyte subsets and immunoglobulins in liver cirrhosis.
    Fiorini G; Monarca A; Natangelo R; Adelasco L; Bigi G; Paracchini ML; Renoldi P; Salomone A; Marinig C
    Quad Sclavo Diagn; 1984 Sep; 20(3):276-82. PubMed ID: 6397761
    [No Abstract]   [Full Text] [Related]  

  • 11. [Local cerebrospinal fluid IgG production in multiple sclerosis].
    Schipper H
    Schriftenr Neurol; 1989; 30():1-91. PubMed ID: 2678429
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of the plasma proteins and HLA in patients with multiple sclerosis and their immediate kindred.
    Baykoushev S; Trendafilova L; Kostova L; Christov L; Naumova E
    Folia Med (Plovdiv); 1984; 26(2):33-7. PubMed ID: 6443657
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in cerebrospinal fluid immunoglobulins during multiple sclerosis].
    Musiani P; Giovannini G; Pozzuoli R
    Riv Patol Nerv Ment; 1969 Apr; 90(2):99-112. PubMed ID: 5000385
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple sclerosis: HLA studies in Italy.
    Conighi C
    Ital J Neurol Sci; 1987 Jun; Suppl 6():41-3. PubMed ID: 3498705
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term treatment of multiple sclerosis with IgG immunotherapy.
    Schuller E; Lambin P; Deloche G
    Pathol Biol (Paris); 1996 Oct; 44(8):710-5. PubMed ID: 8977930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunoglobulin G level determined by disk precipitation test in serum of patients with disseminated sclerosis].
    Strelau K
    Neurol Neurochir Pol; 1971; 5(4):479-83. PubMed ID: 5122053
    [No Abstract]   [Full Text] [Related]  

  • 17. [The behavior of immunoglobulins in multiple sclerosis].
    Cazzullo CL; Montanini R; Paltrinieri E; Giovannucci M
    Acta Neurol (Napoli); 1968; 23(4):589-99. PubMed ID: 4195090
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunopathology of multiple sclerosis: relationship between the development of the disease and serum and cerebrospinal fluid C1-3 levels].
    Cazzullo CL; Smeraldi E; Zibetti A; Bottinelli S
    Acta Neurol (Napoli); 1973; 28(3):255-61. PubMed ID: 4200090
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cellular and humoral immunity in idiopathic proctocolitis].
    Krc I; Kojecký Z; Benýsek L; Güttnerová J; Matousková I
    Vnitr Lek; 1979 Aug; 25(8):742-8. PubMed ID: 506076
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous immunoglobulin treatment in multiple sclerosis.
    Achiron A; Cohen IR; Lider O; Melamed E
    Isr J Med Sci; 1995 Jan; 31(1):7-9. PubMed ID: 7836053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.